Scientists Develop Promising Non-Hormonal Male Birth Control

Got story updates? Submit your updates here. ›

Researchers at Cornell University have discovered a potential new approach to male birth control that does not involve hormones or a vasectomy. In experiments with male mice, they found that a drug called JQ1 can temporarily halt sperm production by interfering with the process of meiosis, which is critical for producing viable sperm cells. The effect was reversible, with the mice regaining full fertility after about 30 weeks.

Why it matters

The development of new male contraceptive options is important, as it could provide more choices for men beyond condoms and vasectomies. Having a variety of birth control methods is key, as some men may not respond well to or want hormonal treatments, which are the closest to being approved. This research represents a promising non-hormonal approach that could eventually lead to a new class of male contraceptives.

The details

The Cornell researchers tested the drug JQ1, which was originally developed as a cancer treatment, on male mice. They found that dosing the mice with JQ1 for three weeks completely halted sperm production without harming the stem cells that produce sperm. The effect began to fade within six weeks after the mice stopped taking the drug, and it took about 30 weeks for their fertility to fully recover. Once recovered, the mice were still able to produce offspring.

• The study was published on April 8, 2026.
• The researchers dosed the male mice with JQ1 for three weeks.

What they’re saying

What’s next

The researchers are already working on other potential treatments intended to safely block sperm meiosis, as JQ1 itself is unlikely to be developed as a male birth control drug due to its short half-life and possible neurological side effects.